Boyuan Yao

12 Wulumuqi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

The value of targeting CXCR4 with 68Ga-Pentixafor PET/MRI for Cushing's disease: a retrospective cohort study.

The value of targeting CXCR4 with 68Ga-Pentixafor PET/MRI for Cushing's disease: a retrospective cohort study.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 18, 2025

Risk of recurrence after successful surgery for Cushing's disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study.

Risk of recurrence after successful surgery for Cushing's disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study.

Journal: The lancet. Diabetes & endocrinology

Published: September 22, 2025

Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: A retrospective cohort study.

Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: A retrospective cohort study.

Journal: Molecular therapy. Oncology

Published: May 10, 2025

Diagnostic Accuracy and Value of CXCR4-targeted PET/MRI Using 68Ga-Pentixafor for Tumor Localization in Cushing Disease.

Diagnostic Accuracy and Value of CXCR4-targeted PET/MRI Using 68Ga-Pentixafor for Tumor Localization in Cushing Disease.

Journal: Radiology

Published: December 17, 2024

FTO-mediated DSP m6A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors.

FTO-mediated DSP m6A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors.

Journal: Molecular cancer

Published: July 09, 2024

Proteogenomic characterization of skull-base chordoma.

Proteogenomic characterization of skull-base chordoma.

Journal: Nature communications

Published: August 09, 2023

Digital image analysis allows objective stratification of patients with silent PIT1-lineage pituitary neuroendocrine tumors.

Digital image analysis allows objective stratification of patients with silent PIT1-lineage pituitary neuroendocrine tumors.

Journal: The journal of pathology. Clinical research

Published: March 30, 2023

Characterization of Somatotrope Cell Expansion in Response to GHRH in the Neonatal Mouse Pituitary.

Characterization of Somatotrope Cell Expansion in Response to GHRH in the Neonatal Mouse Pituitary.

Journal: Endocrinology

Published: March 21, 2023

Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET.

Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET.

Journal: Cell reports. Medicine

Published: August 14, 2022

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.

Journal: Cell research

Published: March 12, 2022

Low-rank fusion convolutional neural network for prediction of remission after stereotactic radiosurgery in patients with acromegaly: a proof-of-concept study.

Low-rank fusion convolutional neural network for prediction of remission after stereotactic radiosurgery in patients with acromegaly: a proof-of-concept study.

Journal: The Journal of pathology

Published: February 13, 2022

Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma.

Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma.

Journal: Cell discovery

Published: January 15, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026